Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children

Lupus

Volumn 22, Issue 5, 2013, Pages 486-491

  Hammad, A ^a   Mosaad, Y ^a   Elhanbly, S ^a   Youssef, H ^b   Refaaey, A El ^a   Elhusseini, F ^a   Bakr, A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

juvenile SLE; lipocalin 2; nephritis; proliferative lupus nephritis; renal lupus; systemic lupus erythematosus; Urinary NGAL

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SCHOOL CHILD; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE-PHASE PROTEINS; ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOCALINS; LUPUS NEPHRITIS; MALE; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84875921611     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313479419     Document Type: Article

References (35)

1. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000 ; 35: 904-914
2. Perfumo F, Martini A. Lupus nephritis in children. Lupus. 2005 ; 14: 83-88
3. Gloor JM. Lupus nephritis in children. Lupus. 1998 ; 7: 639-643
4. Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest. 1995 ; 55: 125-131
5. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996 ; 38: 414-420
6. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003 ; 14: 2534-2543
7. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004 ; 24: 307-315
8. Trachtman H, Christen E, Cnaan A, et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A novel marker of renal injury. Pediatr Nephrol. 2006 ; 21: 989-994
9. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003 ; 63: 1714-1724
10. Devarajan P, Mishra J, Supavekin S, Patterson LT, Steven Potter S. Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 2003 ; 80: 365-376
11. Devarajan P. Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr. 2005 ; 17: 193-199
12. Nguyen MT, Ross GF, Dent CL, Devarajan P. Early prediction of acute renal injury using urinary proteomics. Am J Nephrol. 2005 ; 25: 318-326
13. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006 ; 21: 856-863
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
15. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291
16. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 ; 15: 241-250
17. Illei GG, Tackey E, Lapteva L, Lipsky PE. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum. 2004 ; 50: 2048-2065
18. Illei GG, Tackey E, Lapteva L, Lipsky PE. Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum. 2004 ; 50: 1709-1720
19. Merrill JT, Buyon JP. The role of biomarkers in the assessment of lupus. Best Pract Res Clin Rheumatol. 2005 ; 19: 709-726
20. Hahn BH. Antibodies to DNA. N Engl J Med. 1998 ; 338: 1359-1368
21. Blatt NB, Glick GD. Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacol Ther. 1999 ; 83: 125-139
22. Waldman M, Madaio MP. Pathogenic autoantibodies in lupus nephritis. Lupus. 2005 ; 14: 19-24
23. Qing X, Zavadil J, Crosby MB, et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum. 2006 ; 54: 2198-2210
24. Brunner HI, Mueller M, Rutherford C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2577-2584
25. Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008 ; 23: 403-412
26. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005 ; 365: 1231-1238
27. Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009 ; 60: 2772-2781
28. Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford). 2010 ; 49: 960-971
29. Kiani AN, Wu T, Fang H, et al. Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol. 2012 ; 39: 1231-1237
30. Pitashny M, Schwartz N, Qing X, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum. 2007 ; 56: 1894-1903
31. Cross J, Jayne D. Diagnosis and treatment of kidney disease. Best Pract Res Clin Rheumatol. 2005 ; 19: 785-798
32. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol. 1988 ; 8: 85-89
33. Adams A, MacDermott EJ, Lehman TJ. Pharmacotherapy of lupus nephritis in children: A recommended treatment approach. Drugs. 2006 ; 66: 1191-1207
34. Ka SM, Rifai A, Chen JH, et al. Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant. 2006 ; 21: 288-298
35. Brunner HI, Bennett MR, Mina R, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012 ; 64: 2687-2697